Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2022-03-11 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 90% confidence The document is extremely short (305 characters) and contains only metadata about a virtual investor meeting (Jefferies Mid-Cap Summit) with no financial data, no report content, no regulatory references, or detailed disclosures. It appears to be a brief note or announcement about an investor interaction event rather than a formal report or filing. Given the lack of substantive content, it does not fit into any specific detailed report category. The best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not neatly fit elsewhere.
2022-03-11 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 90% confidence The document is extremely short (191 characters) and contains only a brief table listing a date, an analyst/investor event, and type of interaction (a virtual non-deal roadshow). There is no financial data, no report content, no regulatory references, and no indication of a formal filing or report. It appears to be a simple meeting or event log rather than a formal filing. Given the lack of any other fitting category, the best classification is Regulatory Filings (RNS) as a fallback for miscellaneous brief announcements or logs.
2022-02-21 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is extremely short (191 characters) and contains only a brief table listing a date, an analyst/investor event, and type of interaction (a virtual non-deal roadshow). There is no financial data, no report content, no regulatory references, or detailed disclosures. It is essentially a meeting or event notice without substantive report or financial information. This fits best as a Regulatory Filing (RNS) since it is a miscellaneous announcement that does not fit other categories.
2022-02-21 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is extremely short (191 characters) and contains only a brief table listing a date, an analyst/investor event, and the type of interaction (a virtual non-deal roadshow). There is no substantive financial data, no report content, no regulatory references, or detailed disclosures. It appears to be a simple announcement or record of an investor meeting event. Given the brevity and nature, it does not fit into detailed report categories like Annual Report, Earnings Release, or Call Transcript. It is best classified as a Regulatory Filing (RNS) as a general announcement without a more specific category.
2022-02-21 English
Updates
Regulatory Filings
2022-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is very short (247 characters) and contains only a brief table listing a date, an event (Antique's Annual Investor Conference), and the type of interaction (Meetings-VirtualNDR). There is no detailed financial data, no report content, no regulatory references, or any indication of a formal filing. It appears to be a simple schedule or summary of investor interactions, which does not fit into any specific detailed report category. Given the lack of substantive content, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2022-02-07 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.